About Biofourmis
The Problem Biofourmis addresses a core healthcare pain point: fragmented operations, slow decision cycles, and poor visibility across teams. Organizations in this market often rely on disconnected tools, which creates delays, revenue leakage, and inconsistent customer outcomes.
The Solution Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. Healthcare Biotech In practice, Biofourmis centralizes critical workflows, automates repetitive coordination, and gives operators a real-time system of record. This reduces manual overhead and improves execution quality at scale.
Why it's growing With the rise of digitized healthcare workflows, preventive analytics, and patient-first digital journeys, Biofourmis is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.
Culture The team operates in a fast-paced environment focused on healthcare innovation, product velocity, and customer-centric execution. Their culture emphasizes ownership, experimentation, and measurable outcomes.
Why it Matters
Biofourmis matters now because with the rise of digitized healthcare workflows, preventive analytics, and patient-first digital journeys, Biofourmis is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.
Funding Snapshot
- Series C • Sequoia, $100M Series C in 2020, $700M valuation
Hiring Roles
This company is actively hiring.
Meet the Founders
Biofourmis Team
Founder & CEO